Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Impax reaches $20 mln deal to end trial over generic drug's delay
Impax reaches $20 mln deal to end trial over generic drug's delay
Impax reaches $20 mln deal to end trial over generic drug's delay
Submitted by
admin
on March 29, 2018 - 9:59am
Source:
Yahoo/Reuters
News Tags:
Impax Labs
generics
Solodyn
Headline:
Impax reaches $20 mln deal to end trial over generic drug's delay
Do Not Allow Advertisers to Use My Personal information
